Celgene Corp
CELG
CELG was delisted on the 20th of November, 2019.
1,224 hedge funds and large institutions have $61B invested in Celgene Corp in 2016 Q1 according to their latest regulatory filings, with 109 funds opening new positions, 468 increasing their positions, 488 reducing their positions, and 114 closing their positions.
10% more call options, than puts
Call options by funds: $813M | Put options by funds: $742M
4% less repeat investments, than reductions
Existing positions increased: 468 | Existing positions reduced: 488
4% less first-time investments, than exits
New positions opened: 109 | Existing positions closed: 114
2% less funds holding
Funds holding: 1,246 → 1,224 (-22)
19% less capital invested
Capital invested by funds: $75.7B → $61B (-$14.7B)
23% less funds holding in top 10
Funds holding in top 10: 111 → 85 (-26)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal London Asset Management
United Kingdom
|
+$1.96B |
| 2 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$215M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$212M |
| 4 |
Neuberger Berman Group
New York
|
+$198M |
| 5 |
Edgewood Management
Greenwich,
Connecticut
|
+$186M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$479M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$461M |
| 3 |
Winslow Capital Management
Minneapolis,
Minnesota
|
-$203M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$173M |
| 5 |
Wells Fargo
San Francisco,
California
|
-$156M |
CELG Hedge Fund Activity: Q1 2016 in Review
1,224 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Celgene Corp (CELG) for Q1 2016, worth a combined $61B — down 19% from $75.7B a quarter earlier.
Sellers outnumbered buyers: 114 funds closed out of CELG and 109 opened new positions — a net loss of 5 holders — while 488 trimmed existing stakes and 468 added.
The largest buyer was Royal London Asset Management, adding an estimated $1.96B. The largest seller was JP Morgan Chase, cutting an estimated $479M.
- 1,224 institutional investors held Celgene Corp (CELG) as of Q1 2016, down from 1,246 in Q4 2015.
- Funds reported $61B of Celgene Corp stock for Q1 2016, down 19% quarter-over-quarter.
- 109 funds opened new Celgene Corp positions in Q1 2016 and 114 closed out, a net change of -5 holders.
- The largest Celgene Corp buyer in Q1 2016 was Royal London Asset Management, an estimated $1.96B added.
- The largest Celgene Corp seller in Q1 2016 was JP Morgan Chase, an estimated $479M sold.
Based on aggregated 13F filings for Q1 2016.